Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial year which ...
Turbocharge the Development of the Best-In-Class Kinase Inhibitor Products, to Enhance Specificity, Overcome Resistance to Deliver Safe & Durable Clinical Responses Celebrating 20 years of FDA ...
Tied up in knots: the tiny knotted robot could find applications in agriculture and reforestation. (Courtesy: Bella Ciervo/Penn Engineering) Researchers at the University of Pennsylvania and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results